Back to Market Feed

Product Information

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE is a generic product labeled by Quagen Pharmaceuticals LLC, priced at $2.0089 per EA under NDC 70752014110. Its NADAC has been published 76 times since Mar 12, 2025.

FDA first approved this application on Mar 12, 2024. Its Orange Book therapeutic-equivalence code is AA.

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
$2.0089per EA
DEA Schedule CIII

Strength

325; 50; 40 mg/1; mg/1; mg/1

NDC

70752014110

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA216376

FDA Approved

3/12/2024

TE Code

AA

On Market Since

8/6/2022

Pharmacological Classes

Barbiturate
Barbiturates
Central Nervous System Stimulant
Central Nervous System Stimulation
Methylxanthine
Xanthines

Price Statistics

The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has been published 76 times since Mar 12, 2025, and over the history we have for it it has declined 18.6%. The table below summarizes its recorded NADAC range and movement.

Current price$2.0089 per EA
All-time high$2.7647 (Apr 16, 2025)
All-time low$1.6931 (Jun 17, 2026)
52-week high$2.3000
52-week low$1.6931
Median price$2.2229
Average price$2.1613
Largest weekly change-13.1% (Jun 18, 2025)
Weeks tracked76
Tracking sinceMar 12, 2025

Price History

1W

+10.5%

1M

+10.5%

3M

+16.1%

6M

+3.3%

1Y

-9.6%

3Y

N/A

5Y

N/A

All

-18.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BUTALBITAL, ACETAMINOPHEN AND CAFFEINE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

BACK-BODY PAIN 500-32.5 MG CPLT
Generic
70000012702•Cardinal Health
$0.0422
per EA
EXTRA PAIN RELIEF CAPLET
Generic
49483037000•Time-Cap Labs Inc.
$0.0621
per EA
QC HEADACHE RELIEF TABLET
Generic
63868048501•Chain Drug Marketing Association
$0.0629
per EA
TENSION HEADACHE CAPLET
Generic
70000015901•Cardinal Health
$0.0638
per EA
TENSION HEADACHE CAPLET
Generic
70000015902•Cardinal Health
$0.0638
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037462•L. Perrigo Company
$0.0649
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037478•L. Perrigo Company
$0.0649
per EA
PAIN RELIEVER PLS 250-250-65 MG
Generic
00536132601•Rugby Laboratories
$0.0649
per EA
MIGRAINE 250-250-65 MG CPLT
Generic
24385036571•AmerisourceBergen
$0.0649
per EA
MIGRAINE FORMULA CAPLET
Generic
24385036578•AmerisourceBergen
$0.0649
per EA

Frequently asked questions

What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE, manufactured by Quagen Pharmaceuticals LLC, is $2.0089 per EA (NDC 70752014110), effective Aug 19, 2026.

How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has declined 18.6%. It has been tracked across 76 weekly CMS publications since Mar 12, 2025.

What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?

Since Mar 12, 2025, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has ranged from a low of $1.6931 (Jun 17, 2026) to a high of $2.7647 (Apr 16, 2025), with a median of $2.2229 per EA.

Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE (NDC 70752014110) is labeled by Quagen Pharmaceuticals LLC, and CMS classifies it as a generic product.